SEC Form 4 · accession 0000899243-15-004745
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
HedgePath, LLC
10% Owner
Period of report
Aug 14, 2014
Accepted (ET)
Sep 14, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value per shareF1 | Sep 10, 2015 | S$0 | 20,000,000 | — | D | 84,687,069 | D | |
| Common Stock, $.0001 par value per shareF2 | Aug 14, 2014 | C | 82,156,842 | — | A | 104,687,069 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 10, 2015, the Reporting Person transferred 20,000,000 shares of common stock in a private transaction to a third party in satisfaction of $1,577,797.54 in then outstanding debt.
- F2On August 14, 2014, the Reporting Person converted 241,636.720 shares of its Series A Preferred Convertible Stock into 82,156,842 shares of common stock.